Oct 13, 2021

Featuring perspectives from Dr Carey Anders and Ms Jamie Carroll, including the following topics:

• Introduction (0:00)
• Prologue: The Summer of 2021 — Immunotherapy and PARP inhibitors enter the adjuvant/neoadjuvant settings (4:05)
• Case 1: A woman in her early 60s with ER/PR-positive, HER2-positive metastatic breast cancer — Jamie Carroll, APRN, MSN, CNP (17:19)
• Case 2: A woman in her late 30s with ER/PR-positive, HER2-negative, node-positive localized breast cancer — Ms Carroll (37:23)

NCPD information and select publications